The Saudi Arabia biosimilar market is poised for significant growth, with a projected CAGR of 23.10% from 2024 to 2032. The increasing focus on providing patients with affordable and effective treatment options is driving the demand for biosimilars. https://www.imarcgroup.com/saudi-arabia-biosimilar-market